ELMD
AMEXElectromed Inc.
Price$37.41+1.12 (+3.09%)
01:30 PM03:45 PM
News · 26 weeks13-25%
2025-12-142026-06-07
Mix890d
- Other2(25%)
- Earnings2(25%)
- SEC Filings2(25%)
- Insider2(25%)
Latest news
25 items- INSIDERChief Financial Officer Nagel Bradley M. exercised 9,601 shares at a strike of $10.50 and sold $428,936 worth of shares (11,801 units at $36.35), decreasing direct ownership by 10% to 19,638 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- SECSEC Form SD filed by Electromed Inc.SD - Electromed, Inc. (0001488917) (Filer)
- INSIDERDirector Skarvan Kathleen exercised 40,000 shares at a strike of $3.82 and sold $1,419,358 worth of shares (40,000 units at $35.48) (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Announces Record Financial Performance in Fiscal 2026 Third Quarter18% Revenue growth and strong operating leverage exceeds consensus expectations for the third quarter of fiscal 2026 Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and nine months ended March 31, 2026 ("Q3 FY 2026"). Q3 FY 2026 Company Highlights Net revenues increased 18.4% to a record $18.6 million in Q3 FY 2026, from $15.7 million in the third quarter of the prior fiscal year, led by an 18.6% increase in the core homecare market. Operating income increased to a record $3.8 million, a 76.0% increase from the third quarter of the prior fiscal year, and 20.3% of net revenues. Net
- PRElectromed, Inc. to Report Q3 Fiscal 2026 Financial Results on May 12, 2026Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 third quarter ended March 31, 2026, on Tuesday, May 12, 2026 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780. The live webcast of the call will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Fiscal Q3 2026 Earning
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Electromed Inc.SCHEDULE 13G/A - Electromed, Inc. (0001488917) (Subject)
- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Announces Record Financial Performance in Fiscal 2026 Second QuarterStrong operational execution results in thirteenth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2025 ("Q2 FY 2026"). Q2 FY 2026 Company Highlights Net revenues increased 16.3% to a record $18.9 million in Q2 FY 2026, from $16.3 million in the second quarter of the prior fiscal year, led by an 18.4% increase in the core homecare market. Operating income increased to a record $3.6 million, a 42.4% increase from the second quarter of the prior fiscal year. Operating margin improve
- PRElectromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 second quarter ended December 31, 2025, on Tuesday, February 10, 2026 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live webcast of the call will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electrome
- SECElectromed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- INSIDERDirector Tune Kathleen A was granted 3,000 shares, increasing direct ownership by 25% to 15,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Erickson Stan K. was granted 3,000 shares, increasing direct ownership by 8% to 38,817 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Fluet Gregory was granted 3,000 shares, increasing direct ownership by 17% to 21,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Galatowitsch Joseph L. was granted 3,000 shares, increasing direct ownership by 25% to 15,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Skarvan Kathleen was granted 3,000 shares, increasing direct ownership by 9% to 35,622 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Walsh Andrea M. was granted 3,000 shares, increasing direct ownership by 20% to 18,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Summers Andrew was granted 3,000 shares, increasing direct ownership by 33% to 12,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- SECElectromed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Electromed, Inc. (0001488917) (Filer)
- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Announces First Quarter Fiscal 2026 ResultsStrong operational execution results in twelfth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2025 ("Q1 FY 2026"). Q1 FY 2026 Company Highlights Net revenues increased 15.1% to $16.9 million in Q1 FY 2026, from $14.7 million in the first quarter of the prior fiscal year. Operating income increased to $2.7 million, a 37.8% increase from the first quarter of the prior fiscal year. Net income was $2.1 million, or $0.25 per diluted share, representing an increase of 44.9%, compared to
- PRElectromed, Inc. to Report Q1 Fiscal 2026 Financial Results on November 12, 2025Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 first quarter ended September 30, 2025, on Wednesday, November 12, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Ele
ELMD FAQ
7 questionsWhat does Electromed Inc. do?
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management...Where does ELMD stock trade?
Electromed Inc. (ELMD) is listed on AMEX.What sector and industry is ELMD in?
Electromed Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Electromed Inc. go public?
Electromed Inc. (ELMD) completed its IPO in 2011.What are analysts saying about ELMD?
Electromed Inc. has had 3 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $3600.00 price target on 2025-08-27. Recent price targets range from $2900.00 to $3800.00.What companies are similar to ELMD?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare ELMD side-by-side with any of them on Quantisnow.How can I track ELMD on Quantisnow?
Quantisnow aggregates Electromed Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ELMD to receive live email and push alerts on every new disclosure.